Dopamine D3 receptor specifically modulates motor and sensory symptoms in iron-deficient mice

Journal of Neuroscience

Volumn 31, Issue 1, 2011, Pages 70-77

  Dowling, Pascal ^a   Klinker, Florian ^a   Stadelmann, Christine ^a   Hasan, Kenan ^a   Paulus, Walter ^a   Liebetanz, David ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 3 RECEPTOR; FORMALDEHYDE; IRON; PROTEIN C JUN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; HOT PLATE TEST; IMMUNOHISTOCHEMISTRY; IRON DEFICIENCY; IRON RESTRICTION; MALE; MOTOR DYSFUNCTION; MOUSE; NEUROMODULATION; NONHUMAN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SENSORY DYSFUNCTION; SIGNAL TRANSDUCTION; SLEEP; TREADMILL; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; GENETICS; HEMISPHERIC DOMINANCE; LOCOMOTION; METABOLISM; METHODOLOGY; MOUSE MUTANT; NEWBORN; PAIN; PATHOLOGY; PHYSIOLOGY; POSTERIOR HORN CELL; REACTION TIME; SPINAL CORD; STIMULATION;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; FUNCTIONAL LATERALITY; IRON; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOVEMENT DISORDERS; PAIN; PAIN MEASUREMENT; PHYSICAL STIMULATION; POSTERIOR HORN CELLS; PROTO-ONCOGENE PROTEINS C-JUN; REACTION TIME; RECEPTORS, DOPAMINE D3; RESTLESS LEGS SYNDROME; SPINAL CORD;

EID: 78650915989     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0959-10.2011     Document Type: Article

References (61)

1. Accili D, Fishburn CS, Drago J, Steiner H, Lachowicz JE, Park BH, Gauda EB, Lee EJ, Cool MH, Sibley DR, Gerfen CR, Westphal H, Fuchs S (1996) A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci U S A 93:1945-1949.
2. Adriaensen H, Gybels J, Handwerker HO, Van Hees J (1983) Response properties of thin myelinated (A-delta) fibers in human skin nerves. J Neurophysiol 49:111-122.
3. Akpinar S (1982) Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol 39:739.
4. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4:101-119.
5. Ashkenazi R, Ben-Shachar D, Youdim MB (1982) Nutritional iron and dopamine binding sites in the rat brain. Pharmacol Biochem Behav 17 [Suppl 1]:43-47.
6. Azkue JJ, Liu XG, Zimmermann M, Sandkühler J (2003) Induction of longterm potentiation of C fibre-evoked spinal field potentials requires recruitment of group I, but not group II/III metabotropic glutamate receptors. Pain 106:373-379.
7. Bara-Jimenez W, Aksu M, Graham B, Sato S, HallettM (2000) Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology 54:1609-1616.
8. Benarroch EE (2008) Descending monoaminergic pain modulation: bidirectional control and clinical relevance. Neurology 71:217-221.
9. Bianco LE, Wiesinger J, Earley CJ, Jones BC, Beard JL (2008) Iron deficiency alters dopamine uptake and response to L-DOPA injection in Sprague- Dawley rats. J Neurochem 106:205-215.
10. Bianco LE, Unger EL, Earley CJ, Beard JL (2009) Iron deficiency alters the day-night variation in monoamine levels in mice. Chronobiol Int 26:447-463.
11. Chen JF, Aloyo VJ, Weiss B (1993) Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum. Neuroscience 54:669-680.
12. 3 receptor knock-out mice. J Neurosci 24:11337-11345.
13. Clemens S, Rye D, Hochman S (2006) Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 67:125-130. (Pubitemid 44305475)
14. Dean T Jr, Allen RP, O'Donnell CP, Earley CJ (2006) The effects of dietary iron deprivation on murine circadian sleep architecture. Sleep Med 7:634-640.
15. Dickenson AH, Sullivan AF (1987) Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology 26:1235-1238.
16. Dowling P, Klinker F, Amaya F, Paulus W, Liebetanz D (2009) Irondeficiency sensitizes mice to acute pain stimuli and formalin-induced nociception. J Nutr 139:2087-2092.
17. Dubuisson D, Dennis SG (1977) The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4:161-174. (Pubitemid 8234766)
18. Earley CJ, Allen RP (1996) Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep 19:801-810. (Pubitemid 27131931)
19. Earley CJ, Heckler D, Allen RP (2004) The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med 5:231-235. (Pubitemid 38684216)
20. Earley CJ, Allen RP, Connor JR, Ferrucci L, Troncoso J (2009) The dopaminergic neurons of the A11 system in RLS autopsy brains appear normal. Sleep Med 10:1155-1157.
21. Ekbom KA (1960) Restless legs syndrome. Neurology 10:868-873.
22. Erikson KM, Jones BC, Beard JL (2000) Iron deficiency alters dopamine transporter functioning in rat striatum. J Nutr 130:2831-2837.
23. Fleetwood-Walker SM, Hope PJ, Mitchell R (1988) Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones. J Physiol 399:335-348.
24. Frölich MA, Price DD, Robinson ME, Shuster JJ, Theriaque DW, Heft MW (2005) The effect of propofol on thermal pain perception. Anesth Analg 100:481-486. (Pubitemid 40170546)
25. García-Borreguero D, Allen RP, Kohnen R,Högl B, Trenkwalder C, Oertel W, Hening WA, Paulus W, Rye D, Walters A, Winkelmann J, Earley CJ (2007) Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine- International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med 8:520-530.
26. Grote L, Leissner L, Hedner J, Ulfberg J (2009) Arandomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. Mov Disord 24:1445-1452.
27. Guitart-Masip M, Johansson B, Fernández-Teruel A, Tobeña A, Giménez- Llort L (2008) Divergent effect of the selective D3 receptor agonist pd- 128,907 on locomotor activity in Roman high- and low-avoidance rats: relationship to NGFI-A gene expression in the Calleja islands. Psychopharmacology (Berl) 196:39-49.
28. Heapy CG, Jamieson A, Russel NJW (1987) Afferent C-fiber and A-delta activity in models of inflammation. Br J Pharmacol 90:164p.
29. Heijtz RD, Beraki S, Scott L, Aperia A, ForssbergH (2002) Sex differences in the motor inhibitory and stimulatory role of dopamine D1 receptors in rats. Eur J Pharmacol 445:97-104.
30. Herdegen T, Kovary K, Leah J, Bravo R (1991) Specific temporal and spatial distribution of JUN, FOS, and KROX-24 proteins in spinal neurons following noxious transsynaptic stimulation. J Comp Neurol 313:178-191.
31. Hunt JR, Zito CA, Erjavec J, Johnson LK (1994) Severe or marginal iron deficiency affects spontaneous physical activity in rats. Am J Clin Nutr 59:413-418.
32. Ishizaki K, Sasaki M, Karasawa S, Obata H, Nara T, Goto F (1999) The effect of intrathecal magnesium sulphate on nociception in rat acute pain models. Anaesthesia 54:241-246. (Pubitemid 29126974)
33. Ko S, Zhao MG, Toyoda H, Qiu CS, Zhuo M (2005) Altered behavioral responses to noxious stimuli and fear in glutamate receptor 5 (GluR5)- or GluR6-deficient mice. J Neurosci 25:977-984.
34. Leem JW, Willis WD, Chung JM (1993) Cutaneous sensory receptors in the rat foot. J Neurophysiol 69:1684-1699.
35. Levant B, McCarson KE (2001) D(3) dopamine receptors in rat spinal cord: implications for sensory and motor function. Neurosci Lett 303:9-12.
36. Li J, Simone DA, Larson AA (1999) Windup leads to characteristics of central sensitization. Pain 79:75-82.
37. Li X, Lighthall G, Liang DY, Clark JD (2004) Alterations in spinal cord gene expression after hindpaw formalin injection. J Neurosci Res 78:533-541.
38. Liebetanz D, Baier PC, Paulus W, Meuer K, BährM, Weishaupt JH (2007) A highly sensitive automated complex running wheel test to detect latent motor deficits in the mouse MPTP model of Parkinson's disease. Exp Neurol 205:207-213.
39. Liu XG, Sandkühler J (1995) Long-term potentiation of C-fiber-evoked potentials in the rat spinal dorsal horn is prevented by spinal N-methyl-Daspartic acid receptor blockage. Neurosci Lett 191:43-46.
40. McCall WD, Tanner KD, Levine JD (1996) Formalin induces biphasic activity in C-fibers in the rat. Neurosci Lett 208:45-48.
41. Menalled LB, Dziewczapolski G, Garcia MC, Rubinstein M, Gershanik OS (1999) D3 receptor knockdown through antisense oligonucleotide administration supports its inhibitory role in locomotion. Neuroreport 10:3131-3136.
42. Mendell LM (1966) Physiological properties of unmyelinated fiber projection to the spinal cord. Exp Neurol 16:316-332.
43. Mizuo K, Narita M, Miyatake M, Suzuki T (2004) Enhancement of dopamine-induced signaling responses in the forebrain of mice lacking dopamine D3 receptor. Neurosci Lett 358:13-16.
44. Nordlander NB (1953) Therapy in restless legs. Acta Med Scand 145: 453-457.
45. Paulus W, Trenkwalder C (2006) Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol 5:878-886.
46. Presley RW, Menétrey D, Levine JD, Basbaum AI (1990) Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. J Neurosci 10:323-335.
47. Qu S, Le W, Zhang X, Xie W, Zhang A, Ondo WG (2007) Locomotion is increased in a11-lesioned mice with iron deprivation: a possible animal model for restless legs syndrome. J Neuropathol Exp Neurol 66:383-388.
48. Satija P, Ondo WG (2008) Restless legs syndrome: pathophysiology, diagnosis and treatment. CNS Drugs 22:497-518.
49. Sautel F, Griffon N, Sokoloff P, Schwartz JC, Launay C, Simon P, Costentin J, Schoenfelder A, Garrido F, Mann A, Wermuth CG (1995) Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. J Pharmacol Exp Ther 275:1239-1246.
50. Schattschneider J, Bode A, Wasner G, Binder A, Deuschl G, Baron R (2004) Idiopathic restless legs syndrome: abnormalities in central somatosensory processing. J Neurol 251:977-982.
51. Shepherd GM (1994) Neurobiology. New York: Oxford UP.
52. Shieh GJ, Walters DE (1996) Stimulating dopamine D1 receptors increases the locomotor activity of developing rats. Eur J Pharmacol 311:103-107.
53. Stadelmann C, Brück W, Bancher C, Jellinger K, Lassmann H (1998) Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropathol Exp Neurol 57:456-464.
54. Stiasny-Kolster K, Magerl W, Oertel WH, Möller JC, Treede RD (2004) Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain 127:773-782.
55. Trenkwalder C, Högl B, Benes H, Kohnen R (2008) Augmentation in restless legs syndrome is associated with low ferritin. Sleep Med 9:572-574.
56. Xu M, Koeltzow TE, Santiago GT, Moratalla R, Cooper DC, Hu XT, White NM,Graybiel AM, White FJ, Tonegawa S (1997) Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 19:837-848.
57. Yaksh TL, Hua XY, Kalcheva I, Nozaki-Taguchi N, Marsala M (1999) The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci U S A 96:7680-7686.
58. Yamamoto T, Yaksh TL (1992) Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 77:757-763.
59. Yeomans DC, Pirec V, Proudfit HK (1996) Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: behavioral evidence. Pain 68:133-140.
60. Youdim MB, Yehuda S, Ben-Uriah Y (1981) Iron deficiency-induced circadian rhythm reversal of dopaminergic-mediated behaviours and thermoregulation in rats. Eur J Pharmacol 74:295-301.
61. Zhao H, Zhu W, Pan T, Xie W, Zhang A, Ondo WG, Le W (2007) Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation. J Neurosci Res 85:1065-1076.